Bioxytran, Inc. (BIXT)
OTCMKTS
· Delayed Price · Currency is USD
0.1621
-0.0117 (4.58%)
Apr 25, 2025, 4:00 PM EDT
Bioxytran Employees
Bioxytran had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$788,894
Market Cap
13.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| Elite Pharmaceuticals | 64 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
Bioxytran News
- 17 days ago - Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements - GlobeNewsWire
- 5 weeks ago - Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens - GlobeNewsWire
- 6 weeks ago - Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions - GlobeNewsWire
- 3 months ago - Bioxytran's Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs - GlobeNewsWire
- 7 months ago - Bioxytran's Medical Breakthrough in Fighting All Viruses - Accesswire
- 9 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 10 months ago - Bioxytran Launches Joint Venture with the Heme Foundation for Development of Universal Oxygen Carrier - GlobeNewsWire
- 10 months ago - Bioxytran's Advisor Releases Book on Hyperbaric Oxygenation Related to Stroke & Alzheimer's Patients - GlobeNewsWire